Lynk Pharmaceuticals is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. Lynk Pharmaceuticals was founded by veteran drug hunters from Pfizer, Merck and Johnson & Johnson with collectively more than several decades of rich experiences in drug discovery. Driven by a higher purpose, Lynk aims at growing into a market leader for developing innovative therapies to address unmet medical needs.
左右滑动
看看不一样的万博士
Slide left or slide right,
Check another Dr. Wan
管理团队Leadership
汪俊博士
共同创始人 & 首席科学官
JUN WANGPh.D.
Co-founder & CSO
MICHAEL VAZQUEZ博士
共同创始人&高级副总裁&化学部负责人
MICHAEL VAZQUEZPh.D.
Co-founder, SVP & Head of Chemistry
陈䶮
共同创始人 & 首席运营官
MR. JAROD CHEN
Co-founder & COO
吴昱博士
首席开发官
HENRY WUPh.D.
CDO
个人背景
BACKGROUND
神户大学博士、德州大学博士后;教授
超过30年学术及工业界新药研发经验 (默克、美迪西生物副总裁) ;
Kobe Univ. (Ph.D.); UT S.W. Medical Center (postdoc)
>25 years @ Merck, Medicilon
个人成就
ACHIEVEMENT
在Nature、PNAS、JBC等著名期刊上发表过多篇文章(通讯作者)、超过40篇国际专利.
Invanz, KU-2285, AK-2123
2015年杰出编委(Biochem. Pharmacol.)
2003年默沙东领导奖
1988年中国医学科学院学术奖
三项期刊编委: Biochem. Pharmacol.、ASSAY & Drug Dev. Tech、 In’t. J. Biol. Sci.
Publications in Nature, PNAS, JBC; >40 US global & regional patents.
Distinguished Alumni (2016), Northern Illinois University
Frequently invited speakers at conferences & universities
个人背景
BACKGROUND
杜克大学富卡商学院量化管理硕士(医疗方向)
中国药科大学博士肄业、首尔国立大学访问学者
超过11年医药工业界营销管理及投融资经验(国药、康恩贝、东诚药业、长江资本)
Duke Univ., Fuqua School of Business (MSQM: HA 2020-2022)
China Pharmaceuticals University(Ph.D. candidate) Seoul University (Visiting Scholar)
>11 years @ Changjiang Capital, Sinopharm, Conba
Broad experience in investment and operation
个人成就
ACHIEVEMENT
曾负责多家上市公司产品营销管理
燧池医药创始人
参与过多个生物医药项目投资及投后管理
浙江药学会药事管理专业委员会委员
基金从业资格证
Responsible for product marketing management of several listed companies
Participated in biotech investment & post investment management
Certified mutual fund manager.
Member of Pharmaceutical Management Committee, Zhejiang
Pharmaceutical Association
个人背景
BACKGROUND
美国新泽西州立罗格斯大学博士
超过20年工业界研发经验(罗氏、森林实验室、方恩、希麦迪等)
美国Innotics创始人及首席统计师
前方恩(Fountain)公司首席运营官、首席执行官
希麦迪(CR Medicon)公司创始人、前首席执行官及董事长
Rutgers Univ (Ph.D.)
> 23 years @ Roche, Innotics (Founder), Kendle, Fountain (CEO), CR Medicon (Founder, CEO & Chairman of Board).
个人成就
ACHIEVEMENT
参与和领导了不同的治疗领域进行了200多项临床试验。
领导了20项不同治疗领域的NDA/BLA提交
Led/Participated in over 200 clinical trials in different therapeutic areas. Managed and interacted with multi-disciplinary team members including data managers, statisticians, programmers, medical writers, and clinicians.
Led over 20 NDA/BLA submissions in different therapeutic areas, overall submission strategy design and cross functional team discussion.
顾问委员会Advisors
Dr. Michael Kahn
顾问委员会主席
美国希望之城国家医疗中心贝克曼研究中心生物学系 主任
Dr. Michael Kahn
Chairman of Advisory Board
Chairman, Beckman research Institute, City of Hope, USA